ALDURAZYME® (laronidase) is the first and only
FDA-approved enzyme replacement therapy (ERT) for MPS I

THE ONE FDA-APPROVED
TREATMENT FOR MPS I

ALDURAZYME® is the enzyme replacement therapy (ERT) for patients with Hurler and Hurler-Scheie forms of Mucopolysaccharidosis I (MPS I) and for patients with the Scheie forms who have moderate to severe symptoms.

ALDURAZYME® has NOT been evaluated to treat (Limitation of Use):

  • Patients who have been mildly affected by the Scheie form
  • The central nervous system symptoms

How Aldurazyme
May Help

WHAT DOES ALDURAZYME DO?

Explore Aldurazyme
Potential Side Effects

ALDURAZYME SAFETY

Support for
Patients

CARECONNECTPSS SUPPORT SERVICES